These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1197824)

  • 21. [The impact of changes in levels of calcium, phosphate and magnesium during hemodialysis on autonomic system reactivity as measured by heart rate variability analysis].
    Buda S; Stompór T; Sułowicz W; Kopeć J; Szymczakiewicz-Multanowska A; Janion M
    Przegl Lek; 2000; 57(6):340-5. PubMed ID: 11107869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical study of cardiac arrhythmia during hemodialysis. The first report: a case of calcium involvement in occurrence of ventricular premature beats].
    Nishimura M; Tsuji Y; Kunishige H; Yasui A; Nakanishi T; Hirabayashi M
    Kokyu To Junkan; 1987 Nov; 35(11):1193-8. PubMed ID: 2449713
    [No Abstract]   [Full Text] [Related]  

  • 23. Calcium and phosphorus metabolism in maintenance hemodialysis.
    Ritz E; Mehls O; Krempien B
    Adv Nephrol Necker Hosp; 1980; 9():71-108. PubMed ID: 6773320
    [No Abstract]   [Full Text] [Related]  

  • 24. Changes in total and ultrafilterable plasma calcium and magnesium during hemodialysis.
    Ogden DA; Holmes JH
    Trans Am Soc Artif Intern Organs; 1966; 12():200-4. PubMed ID: 5960703
    [No Abstract]   [Full Text] [Related]  

  • 25. Antihypertensive effect of low calcium dialysis.
    Katzir Z; Michlin A; Boaz M; Biro A; Smetana S
    Isr Med Assoc J; 2005 Nov; 7(11):704-7. PubMed ID: 16308992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salt, sweat, and unclear? Diaphoresis and hypernatremia in end-stage kidney disease: Questions.
    Levy Erez D; Copelovitch L; Denburg M
    Pediatr Nephrol; 2018 Feb; 33(2):251-252. PubMed ID: 28451894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of arterial compliance in patients treated by hemodialysis.
    Level C; Lasseur C; Delmas Y; Cazin MC; Vendrely B; Chauveau P; Gosse P; Combe C
    Clin Nephrol; 2001 Dec; 56(6):435-44. PubMed ID: 11770795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of salt poisoning due to soy sauce ingestion with hemodialysis].
    Sakai Y; Kato M; Okada T; Sagata Y; Goh R; Kohyama A; Sumitomo M
    Chudoku Kenkyu; 2004 Jan; 17(1):61-3. PubMed ID: 15079924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A controlled evaluation of clinical and metabolic effects of dialysate calcium levels during regular hemodialysis.
    Mirahmadi KS; Duffy BS; Shinaberger JH; Jowsey J; Massry SG; Coburn JW
    Trans Am Soc Artif Intern Organs; 1971; 17():118-24. PubMed ID: 5158077
    [No Abstract]   [Full Text] [Related]  

  • 30. Dialysis dementia.
    Lancet; 1973 Jul; 2(7821):159. PubMed ID: 4124088
    [No Abstract]   [Full Text] [Related]  

  • 31. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum calcium in blood pressure regulation during hemodialysis.
    Zawada ET; Bennett EP; Stinson JB; Ramirez G
    Arch Intern Med; 1981 Apr; 141(5):657-8. PubMed ID: 7224747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Metastatic calcinosis or calciphylaxis--a case with serious vascular calcifications during intermittent hemodialysis].
    Pogglitsch H; Feldner H; Stöckl G; Holzer H
    Wien Med Wochenschr; 1970 Jul; 120(30):532-4. PubMed ID: 5513640
    [No Abstract]   [Full Text] [Related]  

  • 34. Assessment of phosphorus and calcium metabolism and its clinical management in hemodialysis patients in the community of Valencia.
    Maduell F; Gorriz JL; Pallardo LM; Pons R; Santiago C;
    J Nephrol; 2005; 18(6):739-48. PubMed ID: 16358233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sevelamer hydrochloride and vitamin D for controlling serum calcium, phosphorus and bone metabolism in patients undergoing hemodialysis].
    Ishida M; Yao N; Yachiku S; Anzai T; Kobayashi T; Ishida H
    Clin Calcium; 2005 Sep; 15 Suppl 1():192-9. PubMed ID: 16279024
    [No Abstract]   [Full Text] [Related]  

  • 36. [Bone disease in patients undergoing chronic hemodialysis treatment and the role in its development of magnesium in drinking water used in the preparation of dialysis solution].
    Ionova D; Monov A; Baldzhiĭski A
    Vutr Boles; 1985; 24(5):54-7. PubMed ID: 4090454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Calcium carbonate for the treatment of hyperphosphatemia in chronic hemodialysis patients].
    Kiss D; Battegay M; Meier C; Lyrer A
    Schweiz Med Wochenschr; 1990 Mar; 120(9):295-8. PubMed ID: 2315655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-calcium dialysate worsens secondary hyperparathyroidism.
    Argilés A; Mion CM
    J Am Soc Nephrol; 1996 Apr; 7(4):635-6. PubMed ID: 8724901
    [No Abstract]   [Full Text] [Related]  

  • 39. [How should we manage serum calcium concentration in an hemodialysed patient?].
    Houillier P
    Nephrol Ther; 2005 Dec; 1 Suppl 4():S330-6. PubMed ID: 17373204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is single-needle hemodialysis still a good treatment in end-stage renal disease?
    Trakarnvanich T; Chirananthavat T; Maneerat P; Chabsuwan S; Areeyakulnimit S
    Blood Purif; 2007; 25(5-6):490-6. PubMed ID: 18187939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.